6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol Uses, Dosage, Side Effects and more
6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
| Trade Name | 6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol |
| Generic | Avotaciclib |
| Avotaciclib Other Names | 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol, Avotaciclib |
| Type | |
| Formula | C13H11N7O |
| Weight | Average: 281.279 Monoisotopic: 281.102508002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
